Research Paper

Gadd45a inhibits cell migration and invasion by altering the global RNA expression

Volume 13, Issue 11   September 2012
Pages 1112 - 1122
http://dx.doi.org/10.4161/cbt.21186
Keywords: Gadd45a, adhesion, invasion, methylation, microarray, migration
Authors: Zhanhai Shan, Guiyuan Li, Qimin Zhan and Dan Li

View affiliations

Abstract:
Gadd45a, the first well-defined p53 downstream gene, can be induced by multiple DNA-damaging agents, which plays important roles in the control of cell cycle checkpoint, DNA repair process and signaling transduction. Our previous findings suggested that Gadd45a maintains cell-cell adhesion and cell contact inhibition. However, little is known about how Gadd45a participates in the suppression of malignancy in human cancer cells. To examine the functions of Gadd45a in cell invasion and metastasis, we performed the adhesion, wound-healing and transwell assays in Gadd45a+/+ and Gadd45a−/− MEF cell lines. We found the adhesion, migration and invasive abilities were much higher in Gadd45a deficient cells. We furthermore applied high-throughput cDNA microarray analysis and bioinformatics analysis to analyze the mechanisms of Gadd45a gene in invasion and metastasis. Compared with the Gadd45a wild type cells, the Gadd45a deficient cells showed a wide range of transcripts alterations. The altered gene pathways were predicted by the MAS software, which indicated focal adhesion,cell communication,ECM-receptor interaction as the three main pathways. Real-time PCR was employed to validate the differentially expressed genes. Interestingly, we figured out that the deregulations of these genes are caused neither by genomic aberrations nor methylation status. These findings provided a novel insight that Gadd45a may involve in tumor progression by regulating related genes expressions.

Received: February 17, 2012; Accepted: June 20, 2012; Published Online: July 24, 2012

Preview:



Full Text Available - Log in!  


Comments

Please Log In to comment on this article.
If you do not have an account Create One Here.

blog comments powered by Disqus

Advertisements